Curative Biosciences Inc
OTC:CBDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Curative Biosciences Inc
OTC:CBDX
|
US |
|
LGBTQ Loyalty Holdings Inc
OTC:LFAP
|
US |
|
Santander Bank Polska SA
OTC:BKZHY
|
PL |
Balance Sheet
Balance Sheet Decomposition
Curative Biosciences Inc
Curative Biosciences Inc
Balance Sheet
Curative Biosciences Inc
| Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
-28%
|
0
-52%
|
0
+230%
|
0
-19%
|
0
-55%
|
0
-87%
|
0
-36%
|
0
-49%
|
0
-55%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
-26%
|
0
-17%
|
0
+126%
|
2
+413%
|
1
-70%
|
0
-43%
|
1
+85%
|
1
-12%
|
1
+2%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
0
|
0
|
3
|
11
|
18
|
48
|
51
|
53
|
53
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
3
|
10
|
18
|
48
|
51
|
52
|
53
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
-300%
|
0
-38%
|
2
-1 661%
|
1
+72%
|
0
+34%
|
1
-90%
|
1
+12%
|
1
-3%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
-28%
|
0
-52%
|
0
+230%
|
0
-19%
|
0
-55%
|
0
-87%
|
0
-36%
|
0
-49%
|
0
-55%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
11
|
16
|
16
|
|